Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Learn what to include in your monthly budget checklist to ensure you cover all necessary expenses. Take control of your financial planning.
17,328 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Pulmonx is navigating a pivotal year as it advances its lung care devices while contending with pacing competition an...
Viemed's 2025 earnings outlook hinges on growing demand for home respiratory care, reimbursement dynamics, and cost c...
As Guidewire charts its path through cloud adoption and insurer modernization, guidewire (gwre) 2026 earnings become ...
Beast Industries has terminated a video editor after Kalshi flagged insider-trading concerns linked to bets on MrBeas...
When Micron stock sinks today, it isn’t just one factor at play. This guide breaks down the drivers, how to read the ...
Liberty Formula One stock trades around $83 after a strong Q4. Jim Cramer flags the pullback as a terrific buying opp...
Conflicts in the Persian Gulf threaten the region’s desalination network, risking drinking water supplies for million...
Investors are watching silver surge with remarkable momentum. This guide shows how the silver 160% year here trend ha...
As Washington rejects a retail CBDC on paper, a private-dollar regime gains power with transfer controls. The questio...
Webull’s March-quarter results reveal a bold pivot: the CEO says B2B revenue could rival or surpass retail in the com...
BYD could shift from a large EV maker to a vertically integrated electrification leader. This piece lays out the thre...